Acid reflux linked with an increased chance of deadly disease such as cancer
(Natural News) People who over-eat should rein in their eating habits this new year, warns a study. Researchers from the Tulane University School of Medicine discovered that frequent heartburn in older adults increases the risk of throat, tonsil, and sinus cancer in older people. In the study, the existence of heartburn increased the likelihood of developing the diseases... (Source: NaturalNews.com)
Source: NaturalNews.com - November 11, 2018 Category: Consumer Health News Source Type: news

AHA: Fish Oil, Vitamin D Not VITAL to Heart Health
(MedPage Today) -- VITAL trial also showed no benefits for cancer incidence with both supplements (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - November 11, 2018 Category: Pediatrics Source Type: news

NHS patients set to have access to breakthrough drug
Thousands of NHS patients with a genetic type of ovarian cancer will soon have access to a new treatment, hailed as a wonder drug, that slashes the risk of death from the condition by 70 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2018 Category: Consumer Health News Source Type: news

Fish Oil, Vitamin D No Help for Heart Risk, Cancer
And new study finds no reason to get routine vitamin D tests, researchers say. (Source: WebMD Health)
Source: WebMD Health - November 10, 2018 Category: Consumer Health News Source Type: news

New Studies Give Mixed Results About Taking Fish Oil and Vitamin D
(CHICAGO) — Taking fish oil or vitamin D? Big studies give long-awaited answers on who does and does not benefit from these popular nutrients. Fish oil taken by healthy people, at a dose found in many supplements, showed no clear ability to lower heart or cancer risks. Same for vitamin D. But higher amounts of a purified, prescription fish oil slashed heart problems and heart-related deaths among people with high triglycerides, a type of fat in the blood, and other risks for heart disease. Doctors cheered the results and said they could suggest a new treatment option for hundreds of thousands of patients like these. ...
Source: TIME: Health - November 10, 2018 Category: Consumer Health News Authors: MARILYNN MARCHIONE / AP Tags: Uncategorized onetime Supplements Source Type: news

VITAL: No CVD or Cancer Benefit From Vitamin D, Omega-3 VITAL: No CVD or Cancer Benefit From Vitamin D, Omega-3
There were no significant reductions in major cardiovascular events or incidence of cancer, the two primary endpoints, in those who took omega-3 or vitamin D supplements in this large and diverse trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Vitamin D And Fish Oil Supplements Mostly Disappoint In Long-Awaited Research Results
After years of debate, a major government funded study failed to find any overall benefit of taking widely used supplements to protect against heart disease or cancer.(Image credit: Cathy Scola/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - November 10, 2018 Category: Consumer Health News Authors: Patti Neighmond Source Type: news

Vitamin D And Fish Oil Supplements Disappoint In Long-Awaited Study Results
After years of debate, a major government funded study failed to find any overall benefit of taking widely used supplements to protect against heart disease or cancer.(Image credit: Cathy Scola/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - November 10, 2018 Category: Consumer Health News Authors: Patti Neighmond Source Type: news

Fish Oil and Vitamin D Supplements May Not Help Prevent Heart Attacks and Cancer, Study Says
There’s good evidence that fish oil supplements may lower the risk of second heart events — like a heart attack or stroke — in people with heart disease, but few rigorous studies have investigated whether the supplement can help people to lower their risk of having a heart event in the first place. And while some data suggests that people with lower levels of vitamin D tend to have higher rates of heart disease and cancer, the evidence isn’t solid. Now, a new study published in the New England Journal of Medicine and presented at the annual meeting of the American Heart Association offers more findi...
Source: TIME: Health - November 10, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs Source Type: news

Vitamin D, omega-3 supplements do not prevent cancer or heart disease, study says
Vitamin D and omega-3 supplements do not prevent cancer or heart disease, a new study finds, the latest in the years-long debate over their benefits. (Source: CNN.com - Health)
Source: CNN.com - Health - November 10, 2018 Category: Consumer Health News Source Type: news

Vitamin D and Fish Oils Are Ineffective for Preventing Cancer and Heart Disease
The largest study to test vitamin D and omega-3 pills in healthy adults found they did little to prevent cardiovascular disease, but hinted at benefits for groups including African-Americans. (Source: NYT Health)
Source: NYT Health - November 10, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Cancer Heart Stroke Dietary Supplements and Herbal Remedies Vitamin D Omega-3 Fatty Acids Vitamins Fish and Other Marine Life Preventive Medicine Deaths (Fatalities) Source Type: news

Artificial intelligence could help doctors identify hard-to-spot colon polyps
Colon cancer is the second leading cause of cancer-related deaths in the U.S. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 10, 2018 Category: Consumer Health News Source Type: news

Jury delivers $25.5 million 'statement' to Aetna to change its ways
An Oklahoma jury has awarded $25.5 million to the family of a cancer patient denied coverage by Aetna, with jurors saying that the insurer acted "recklessly" and that the verdict was meant as a message for Aetna to change its ways. (Source: CNN.com - Health)
Source: CNN.com - Health - November 10, 2018 Category: Consumer Health News Source Type: news

How AI could help doctors identify hard-to-spot colon polyps
"Colon cancer is the second-leading cause of cancer-related deaths in the U.S. but colonoscopies have been found to reduce the risk of death from the disease by 70 percent or more by detecting cancer early. But doctors don ’t always find every polyp. As a gastroenterologist, CBS News chief medical correspondent Dr. Jon LaPook knows all too well that colon polyps can be tough to spot. But a new high-tech tool may be able to help doctors spot them. " (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 10, 2018 Category: Consumer Health News Source Type: news

Cancer warning - does your voice sound like this? The signs hidden when you speak revealed
CANCER symptoms vary depending on which part of the body is affected by a tumour. But you could be at risk of cancer signs if your voice has this characteristic sound. Do you sound like this when you talk? (Source: Daily Express - Health)
Source: Daily Express - Health - November 10, 2018 Category: Consumer Health News Source Type: news

A systematic review summarizing the state of evidence on bullying in childhood cancer patients/survivors - Collins DE, Ellis SJ, Janin MM, Wakefield CE, Bussey K, Cohn RJ, Lah S, Fardell JE.
BACKGROUND: One in four school-aged children is bullied. However, the risk may be greater for childhood cancer patients/survivors (diagnosed ... (Source: SafetyLit)
Source: SafetyLit - November 10, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

VITAL study: How vitamin D and fish oil affect risk of heart attack, stroke and cancer
(Brigham and Women's Hospital) Brigham and Women's Hospital investigators leading the VITamin D and OmegA-3 TriaL (VITAL) conducted a rigorous placebo-controlled trial over the course of 5.3 years, gleaning a treasure trove of information on the effects of both supplements. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 10, 2018 Category: Cancer & Oncology Source Type: news

Many Women Have Not Heard of Ovarian Cancer Before Dx
Nine in 10 women experience multiple symptoms prediagnosis; eight in 10 of them consult a doctor (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 10, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Institutional, Source Type: news

Weight loss after menopause tied to lower breast cancer risk
(Reuters Health) - Older women who lose weight may have a lower risk of developing invasive breast cancer than those who maintain or gain weight, a large U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 10, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Deep Learning Algorithm Aids in Assessing Breast Density
Algorithm may help better predict how likely it is a woman will have cancer in her future. (Source: Diagnostic Imaging)
Source: Diagnostic Imaging - November 9, 2018 Category: Radiology Authors: Diagnostic Imaging Staff Tags: Breast Imaging Dense Breasts Source Type: news

Biotech unicorn Moderna files for IPO of up to $500M
One of the biotech industry's largest unicorns, Cambridge-based Moderna Therapeutics, is planning to go public with an IPO of as much as $500 million, according to documents filed Friday. Moderna is developing messenger RNA molecules, including cancer vaccines, that executives estimates could impact dozens of diseases. The company currently has 10 drug products in clinical trials and another 11 drugs in preclinical development. The company filed documents with the SEC on Friday t o seek up to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 9, 2018 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Biotech unicorn Moderna files for IPO of up to $500M
One of the biotech industry's largest unicorns, Cambridge-based Moderna Therapeutics, is planning to go public with an IPO of as much as $500 million, according to documents filed Friday. Moderna is developing messenger RNA molecules, including cancer vaccines, that executives estimates could impact dozens of diseases. The company currently has 10 drug products in clinical trials and another 11 drugs in preclinical development. The company filed documents with the SEC on Friday t o seek up to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 9, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Update from the Dean – November 2018
Curriculum transformation, An expanded role, Gaining recognition, Graduate match rate; School of Pharmacy scientists receive UCSF Medal: Founding fathers of drug discovery honored; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Advancing the fight against cancer, Combining drug therapies, Mapping cells; In memoriam: Robert D. Gibson A lifetime of pharmacy and advocacy (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - November 9, 2018 Category: Universities & Medical Training Authors: Eric Davila Source Type: news

& #039;Game-changing & #039; New Treatment for NHS Lymphoma Patients
Cancer patients in England will receive a new game-changing therapy treatment under the first negotiated deal of its kind struck in Europe. (Source: CancerNetwork)
Source: CancerNetwork - November 9, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Does Eating Organic Foods Decrease Cancer Risk?
We spoke with Kelly Hogan, MS, RD, about the recent JAMA study on the association between organic food consumption and cancer risk. (Source: CancerNetwork)
Source: CancerNetwork - November 9, 2018 Category: Cancer & Oncology Authors: Lori Smith, BSN, MSN, CRNP Source Type: news

Study in Cancer shows early mammography saves women's lives
Women who adhere to early and regular screening mammography have lower mortality...Read more on AuntMinnie.comRelated Reading: DBT doesn't hurt screening throughput DBT spots 34% more breast cancers than mammography AI reduces false positives in screening mammography Synthesized 2D similar to FFDM for finding microcalcs Breast screening critics Gotzsche, Welch lose positions (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 9, 2018 Category: Radiology Source Type: news

Many Women Have Not Heard of Ovarian Cancer Before Dx
FRIDAY, Nov. 9, 2018 -- Many women are not knowledgeable about ovarian cancer before diagnosis despite most women experiencing prediagnosis symptoms, according to a report published online Oct. 18 by the World Ovarian Cancer Coalition. Researchers... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2018 Category: Pharmaceuticals Source Type: news

Age Just a Number for Older, Fit Limited-Stage SCLC Patients
(MedPage Today) -- Standard chemoradiotherapy proved just as effective compared with younger patients (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 9, 2018 Category: Hematology Source Type: news

Mammograms Do Save Lives, Study Shows
People with breast cancer who took part in a breast cancer screening program had a 60 percent lower risk of dying from the disease in the 10 years after diagnosis, and a 47 percent lower risk 20 years after diagnosis, Swedish researchers report. (Source: WebMD Health)
Source: WebMD Health - November 9, 2018 Category: Consumer Health News Source Type: news

Mammograms Do Save Lives: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 9, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Oncology, Radiology, News, Source Type: news

Income, Lifestyle May Contribute to Disparity in Cancer Deaths
In addition to health care factors, issues outside of treatment may affect cancer death rates (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 9, 2018 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Nursing, Oncology, Journal, Source Type: news

Genetic Test Helps ID Benign Versus Malignant Thyroid Nodules
ThyroSeq v3 has 94 percent sensitivity, 82 percent specificity for Bethesda III and IV nodules (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 9, 2018 Category: Cancer & Oncology Tags: Endocrinology, Oncology, Pathology, Journal, Source Type: news

VEGF is a major contributor to cancer growth: What you need to know about this growth mechanism
(Natural News) Cancer remains as one of the least understood diseases in the world, making it extremely difficult to prevent and treat. Over the years, the number of patients suffering from this condition continues to soar. According to the American Cancer Society, the number of newly diagnosed cancer cases for 2018 is expected to reach... (Source: NaturalNews.com)
Source: NaturalNews.com - November 9, 2018 Category: Consumer Health News Source Type: news

The Indian gooseberry and chameleon plant contain compounds that kill cancer cells
(Natural News) The cost of chemotherapy is often too hard to bear. Even disregarding the physical effects of the dangerous “treatment,” the financial strain alone could force cancer patients to flirt dangerously with despair, or worse, potentially fatal “quick cures.” Yet many people forget that the solution to their condition may be in natural medicine,... (Source: NaturalNews.com)
Source: NaturalNews.com - November 9, 2018 Category: Consumer Health News Source Type: news

One of the oldest traditional herbal medicines, the cancer bush is a possible cure for tuberculosis
(Natural News) The cancer bush (Sutherlandia frutescens) was used in traditional African medicine as a treatment for tuberculosis (TB). Researchers, in a study published in the journal BMC Complementary and Alternative Medicine, investigated the plant’s potential as a treatment for TB. The cancer bush has a long history in African medicine. As the authors put it,... (Source: NaturalNews.com)
Source: NaturalNews.com - November 9, 2018 Category: Consumer Health News Source Type: news

Systemic Therapy Options for Renal Cell Carcinoma
Monty Pal and Charles Ryan discuss systemic therapeutic options and current clinical trials in the renal cell carcinoma space.11/09/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - November 9, 2018 Category: Urology & Nephrology Source Type: news

Scientists look at a traditional Ayurvedic herb as a natural cure for cancer
(Natural News) The potential of antioxidants in cancer treatment and prevention has become the subject of many scientific endeavors. Among these is the study conducted by researchers from Vellore Institute of Technology, which revealed the ability of the Indian trumpet flower (Oroxylum indicum (L.)) to inhibit oxidative stress and protect the liver from damage that... (Source: NaturalNews.com)
Source: NaturalNews.com - November 9, 2018 Category: Consumer Health News Source Type: news

Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study
Despite an overall increase in the incidence of RCC, there has been a recent plateau in RCC incidence rates with a significant decrease in mortality.11/09/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - November 9, 2018 Category: Urology & Nephrology Source Type: news

Personalized Immunotherapy Combinations on Horizon
Future development of novel immunotherapy combinations should be based on individual patient characteristics, such as patient-level immune targets and tumor microenvironment, according to a presentation by Jason Luke, MD, at the 36th Annual CFS.11/09/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - November 9, 2018 Category: Urology & Nephrology Source Type: news

Sunitinib Alone or after Nephrectomy in Renal Cancer
In the CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangiog éniques) trial, Méjean et al. (Aug. 2 issue)1 determine the noninferiority of sunitinib alone, as compared with nephrectomy followed by sunitinib, on the basis of the observation that the 95% confidence interval for the hazard ratio of death did not exceed 1.20 (the noninferiority margin for t he trial).11/09/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - November 9, 2018 Category: Urology & Nephrology Source Type: news

Elekta highlights Unity abstracts at ASTRO
Radiation oncology vendor Elekta is highlighting the findings covered in nearly...Read more on AuntMinnie.comRelated Reading: Elekta acquires software firm Acumyn York Instruments buys Elekta's MEG business Elekta partners with NY cancer center on radiation therapy China clears Elekta's Gamma Knife Icon Elekta inks reseller agreement with Equicare Health (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 9, 2018 Category: Radiology Source Type: news

No Cosmetic Difference With Hypofractionated WBI in Breast Ca
(MedPage Today) -- Equivalent to conventionally fractionated approach in early-stage disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 9, 2018 Category: Hematology Source Type: news

Arti Hurria, MD,'Giant' in Geriatric Oncology, Dies in Accident Arti Hurria, MD,'Giant' in Geriatric Oncology, Dies in Accident
Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

U of Missouri becomes first to ship isotope for thyroid cancer in U.S.
The University of Missouri Research Reactor (Image courtesy of the University of Missouri) The University of Missouri Research Reactor (MURR) recently shipped its first batch of a medical isotope used to diagnose and treat thyroid cancer, making it the first domestic source of Iodine-131 (I-131) in 30 years. I-131 has only an eight-day half-life, making stockpiling impossible, and demand is expected to increase. Thyroid cancer is “the most rapidly increasing cancer in the U.S.,” with diagnoses tripling in the last three decades, according to the American Cancer Society. The National Cancer Institute e...
Source: Mass Device - November 9, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Diagnostics Featured Oncology internationalisotopesinc. Shine Medical Technology University of Missouri Source Type: news

US-CNB Superior for Axillary Staging in Breast Cancer US-CNB Superior for Axillary Staging in Breast Cancer
Dr Lowenfels reviews a study that compares diagnostic accuracy of ultrasound-guided fine-needle aspiration and ultrasound-guided core-needle biopsy for axillary staging in breast cancer.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2018 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Cancer specialists slam decision by health watchdog to NOT recommend a drug for ovarian cancer
Nice has ruled against expanding the use of groundbreaking drug olaparib, developed by British scientists. Charity cancers call it a 'bitter blow' to thousands who could miss out. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2018 Category: Consumer Health News Source Type: news

ThyroSeq Test Helps Avoid Unnecessary Thyroid Surgeries ThyroSeq Test Helps Avoid Unnecessary Thyroid Surgeries
The multigene molecular classifier ThyroSeq shows high sensitivity, specificity, and detailed genetic profiles, allowing fewer unnecessary diagnostic surgeries for indeterminate thyroid nodules.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight The MAReport: read the Summer/Fall 2018 issue of the MAReport newsletter! Have you had the chance to meet our Health Programming Coordinator? Learn more about the newest member of the MAR team, Michael Balkenhol! DOCLINE users! Please review the DOCLINE 6.0 Preview Checklist. Questions or concerns? Contact the DOCLINE Coordinating Office (NDCO) via email: DOCLINE@hshsl.umaryland.edu or telephone: (410) 706-4173. National Network of Libraries of Medicine News NNLM All of Us Community Engagement Awards: NNLM MAR is accep...
Source: NN/LM Middle Atlantic Region Blog - November 9, 2018 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Surprising Research on Cannabis
Much of what we think we know about cannabis may soon change as a result of new research that uncovers some surprising facts. Indeed, the topic, which can be emotionally charged, is the focus of intense scientific study. Is cannabis good for you? Is it addictive? What long-term harms can use cause? The answers to these questions are multi-layered and not always clear-cut, which is why cannabis research continues with even more urgency. FACTS ON CANNABIS ADDICTION AND DEPENDENCE Current estimates are that one in 10 cannabis users will develop cannabis addiction or dependence. The potency of the delta-9-tetrahydrocannabinol ...
Source: Psych Central - November 9, 2018 Category: Psychiatry Authors: Suzanne Kane Tags: Addictions Habits Healthy Living Memory and Perception Miscellaneous Drugs Neuroscience Substance Abuse Source Type: news